heparin anticoagulation Articles
-
A reliable rapid functional lab test to help in diagnosing heparin-induced thrombocytopenia (HIT) in daily practice
Recently brought under the spotlights because of the Astra-Zeneca anti-COVID 19 vaccine-associated thrombosis, HIT is a potentially life-threatening complication of treatment with anticoagulant heparin whose diagnostic work-up is still an issue. An article recently published in Biomedicines reported the performance of a rapid flow cytometry-based assay (FCA) as being like the performance of ...
-
Animal study results has been be presented by Prof. Bart Meuris during the Heart Valve Society (HVS) Meeting 2021
In-vivo Evaluation Of A Novel Surgical Heart Valve Prosthesis Designed To Be Durable, Anticoagulant-free And Silent. Bart Meuris, Lucas Van Hoof, Wilm Decré, Marie Lamberigts, Tom Langenaeken, Peter Verbrugghe. KU Leuven, Leuven, Belgium. OBJECTIVE: Heart valves prostheses still face limitations: reoperations with tissue valves or lifelong anticoagulation with mechanical valves. The ...
By Novostia SA
-
How Much Do You Know about Glycosaminoglycans?
Glycosaminoglycan (GAG) is a general term for the glycan part of proteoglycan macromolecules. Glycosaminoglycans are large linear polysaccharides composed of repeating disaccharide units, and their main configuration contains amino sugars and uronic acids (glucuronic acid and/or iduronic acid). Glycosaminoglycans can be divided into chondroitin sulfate, dermatan sulfate, keratan sulfate, ...
By CD BioGlyco.
-
Anticoagulants and Rat Poison
What do rat poison and anticoagulation medicine have in common? As often happens in scientific discovery, research follows a twisted route to the most effective remedy. ...
-
HIT Weekly Series Episode 6 - Conclusions
Today, HIT remains a critical clinical context in many hospital settings, when heparin, mainly unfractionated, is used in cardiology, intensive care units, or ECC, including CPB and increasingly ECMO. This is a paradoxal disease, as this anticoagulant drug can provoke thrombocytopenia associated with thrombosis in affected patients. Detecting the risk of HIT is mandatory, as it requires an ...
-
How One Smart MedTech Company is Leveraging Innovation to Save the Lives and Limbs of VTE Patients
Medical device start-up companies must focus on innovation, regulatory compliance, efficient processes and prudent financial management in order to survive. Smart MedTech companies prioritize their funding to only support innovation which will result in new products that fulfill significant unmet clinical needs over the long-term. Thrombolex, a relatively new entrant into the MedTech sector, is a ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you